EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Safety of 200iU of intravesical Botox in children of all ages with functional urinary incontinence

Eliza Szwarcberg, Chris Kimber, Kiarash Taghavi

Pediatric Surgery International · 2025

DOI: 10.1007/s00383-025-06106-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Surgery International, 2025. Verfasst von Eliza Szwarcberg und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Urology, Monash Children's Hospital, 246 Clayton Rd, Clayton, Melbourne, VIC, 3168, Australia. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Urinary Incontinence, Neuromuscular Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Monash University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Intravesical Botox injection can be effective in children with functional urinary incontinence refractory to conservative measures. A wide range of potential doses have been reported with concerns regarding the safety of higher doses. This study aims to determine the safety and side effect profile of 200iU of Botox in children of all ages with functional urinary incontinence.

Methods

A retrospective review of 143 children who received 200iU of botulinum toxin A utilising intradetrusor injections was performed. All children had urinary incontinence with no defined neurological abnormality. Post-operative complications were analysed, including UTI, adverse drug reactions, pain, haematuria, urinary retention, transitory increased incontinence and systemic adverse effects.

Results

A total of 228 injection procedures (range: 1–6 procedures) in 143 children (70 girls, 73 boys) were included. Median age at first treatment was 9 years (range: 4–17 years). The mean number of treatment cycles required per patient was 1.59 (range: 1–6). There were no intra-operative complications. Post-operative complications included UTI, post-operative pain and haematuria. No complication required re-admission and no cases of urinary retention requiring catheterisation occurred.

Conclusion

This study represents the largest population to date of children with functional urinary incontinence treated with intravesical Botox, confirming this as a well-tolerated, safe intervention in all ages with complications as would be expected for cystoscopy alone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Botulinum Toxins, Type AUrinary IncontinenceNeuromuscular AgentsHumansFemaleMaleChildRetrospective StudiesAdministration, IntravesicalChild, PreschoolAdolescentTreatment Outcome

Stichwörter der Autor:innen

Botulinum toxinsPaediatricsType AUrinary incontinence

Substanzen

Botulinum Toxins, Type ANeuromuscular Agents

Autor:innen und Institutionen

  • Department of Paediatric Urology, Monash Children's Hospital, 246 Clayton Rd, Clayton, Melbourne, VIC, 3168, Australia.
  • Department of Paediatrics, School of Clinical Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia.
  • Department of Paediatric Urology, Monash Children's Hospital, 246 Clayton Rd, Clayton, Melbourne, VIC, 3168, Australia. kiarash.taghavi@monashhealth.org.
  • Department of Paediatrics, School of Clinical Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia. kiarash.taghavi@monashhealth.org.

Förderung

  • Monash University

Zitieren

APA

Szwarcberg, E., Kimber, C., & Taghavi, K. (2025). Safety of 200iU of intravesical Botox in children of all ages with functional urinary incontinence. Pediatric Surgery International. https://doi.org/10.1007/s00383-025-06106-7

Vancouver

Szwarcberg E, Kimber C, Taghavi K. Safety of 200iU of intravesical Botox in children of all ages with functional urinary incontinence. Pediatric Surgery International. 2025. doi:10.1007/s00383-025-06106-7

BibTeX
@article{Szwarcberg2025,
  author = {Szwarcberg, Eliza and Kimber, Chris and Taghavi, Kiarash},
  title = {Safety of 200iU of intravesical Botox in children of all ages with functional urinary incontinence},
  journal = {Pediatric Surgery International},
  year = {2025},
  doi = {10.1007/s00383-025-06106-7}
}
Kostenlos starten →